Basel, 20 April 2020
The MPP General Assembly took place on 2 April 2020, with key highlights including the election of a new representative from Swiss Medtech to the Board and the formation of a new Working Group.
The Elections for the MPP Board saw Daniel Delfosse from Swiss Medtech elected as a new member, while the existing Board Members; Manfred Mäder (Novartis), Stephan Affolter (Ypsomed) and Thomas Kühler (Sanofi) were all re-elected, along with Shayesteh Fürst-Ladani (SFL Regulatory Affairs & Scientific Communication) who was confirmed as President. Mr Delfosse brings more than 20 years of experience working across medical device product development, innovation and regulations in the medtech industry.
The General Assembly also announced the formation of a new MPP Working Group on “Connected Combined Products”. It recognizes the increasing importance of complex connected combined products to deliver precision treatments that can greatly enhance the quality of life for patients. This Working Group will operate alongside the existing highly successful “Combined Products Working Group”.